COVID-19 se asocia a un mayor riesgo de desarrollar el síndrome de Guillain-Barré, un trastorno autoinmune raro pero grave, según un nuevo estudio
Related Posts
Ahora, el mayor aumento de peso ocurre en la adultez temprana
MARTES, 5 de julio de 2022 (HealthDay News) -- La epidemia de obesidad no se...
Vast Majority of Atrial Fibrillation Ablation Procedures Successful
WEDNESDAY, March 29, 2023 (HealthDay News) -- Successful pulmonary vein...
Transition to Long-Term Opioid Use High in Patients With Rheumatic Disease
TUESDAY, May 23, 2023 (HealthDay News) -- For patients living with rheumatic and...
Pfizer Will Ask FDA to Approve Its COVID Vaccine for Kids Under 5
TUESDAY, Feb. 1, 2022 (HealthDay News) -- Pfizer Inc. plans to ask the U.S. Food...